Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.

NCT04291300 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04291300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lutetium-177-PSMA Radioligand Therapy for Advanced Salivary Gland Cancer, a Phase II Pilot Study.
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
May 26, 2020
Completion date
February 13, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoid cystic carcinoma, salivary duct carcinoma, salivary gland cancer